- Event: Navigating Life Sciences M&A Under the Biden Administration | Drug Pricing & Antitrust Considerations (March 25, 2021)
- Podcast: Non-binding Guidance: FDA Regulatory Developments in AI and Machine Learning
(March 4, 2021)
- FDA Publishes Action Plan for Oversight of Artificial Intelligence/Machine Learning-Based Medical Software
(February 9, 2021)
- 2020 Enforcement Review: FDA-Regulated Medical Products and Food Safety (January 28, 2021)
- The 2020 Election and Life Sciences (December 1, 2020)
- In Law360, Attorneys Examine Change in FDA's Review Priorities for COVID-19 Lab-Developed Tests (October 22, 2020)
- In Bloomberg Law, Greg Levine Evaluates FDA Plans for Permanent COVID-19 Test Authorization (October 20, 2020)
- Greg Levine and Ed McNicholas Recognized as 2020 Washington D.C. Trailblazers by The National Law Journal (September 2, 2020)
Cookie Settings
